Analyst Ratings for Bristol-Myers Squibb Co. (BMy)
BMy Rating Summary
BMy Price Target Summary
- Highest: $75.00 (Barclays)
- Lowest: $40.00 (Morgan Stanley)
- Average: $64.35
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$64.35 (+0.8%)
* Over Last 12-Mos
Rating Score: 3.2 / 10
Percentile Rank: 27%
Rating Score: 3.2 / 10
Percentile Rank: 27%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/5/2026 | Argus | Jasper | Upgrade | Buy (Hold) |
75.00 (N/A) |
65.89 (63.83) |
-3.13% | Details |
| 2/24/2026 | RBC Capital » Updated 8/4/2026 |
Trung Huynh | New Coverage | Sector Perform (N/A) |
64.00 (N/A) |
61.25 (63.83) |
4.21% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
